Neurometabolic devices developer EnteroMedics has completed the acquisition of BarioSurg.

The acquisition enables EnteroMedics to access the target company’s Gastric Vest System, which is a minimally invasive, laparoscopically implanted medical device being investigated for weight loss in morbidly obese patients.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

EnteroMedics has paid $2m in cash, 1.38 million unregistered shares of its common stock, and one million unregistered shares of its conditional convertible preferred stock.

Finesse Medical has been acquired by Avery Dennison, as a part of its long-term strategic goal for industrial and healthcare materials segment.

Finesse Medical specialises in developing wound care and skin treatment products using advanced technologies, while Avery, through its business unit Vancive Medical Technologies, provides pressure-sensitive and functional materials for the retail apparel market.

See Also:

"Finesse’s innovative portfolio of silicone gels and polyurethane foam dressings will complement Avery’s existing products in wound care, while it will also provide new global sales and distribution channels for Avery's products."

Finesse’s innovative portfolio of silicone gels and polyurethane foam dressings will complement Avery’s existing products in wound care, while it will also provide new global sales and distribution channels for Avery's products.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Royal Philips intends to acquire respiratory care products developer Respirtech to further expand its business unit, especially in the chronic obstructive pulmonary disease (COPD) segment.

The acquisition will strengthen Royal Philips’ respiratory care portfolio with the target company’s vest therapy solution and capabilities.

Tissue Regenix plans to purchase CellRight Technologies.

Based in Texas, US, CellRight is a biologics company specialising in the development of human osteoinductive and wound care scaffolds for use in general orthopaedic, dental and sports medicine surgical procedures.